Showing 1 - 6 results of 6 for search 'Olga Lomovskaya', query time: 0.03s Refine Results
  1. 1
    Identification and characterization of CIM-1, a carbapenemase that adds to the family of resistance factors against last resort antibiotics

    Identification and characterization of CIM-1, a carbapenemase that adds to the family of resistance factors against last resort antibiotics by Yu Wang, Sylvia A. Sapula, Jonathan J. Whittall, Jack M. Blaikie, Olga Lomovskaya, Henrietta Venter

    Published 2024-03-01
    Get full text
    Article
  2. 2
    QPX7728, An Ultra-Broad-Spectrum B-Lactamase Inhibitor for Intravenous and Oral Therapy: Overview of Biochemical and Microbiological Characteristics

    QPX7728, An Ultra-Broad-Spectrum B-Lactamase Inhibitor for Intravenous and Oral Therapy: Overview of Biochemical and Microbiological Characteristics by Olga Lomovskaya, Ruslan Tsivkovski, Dongxu Sun, Raja Reddy, Maxim Totrov, Scott Hecker, David Griffith, Jeffery Loutit, Michael Dudley

    Published 2021-07-01
    Get full text
    Article
  3. 3
    Molecular determinants of avoidance and inhibition of Pseudomonas aeruginosa MexB efflux pump

    Molecular determinants of avoidance and inhibition of Pseudomonas aeruginosa MexB efflux pump by Silvia Gervasoni, Jitender Mehla, Charles R. Bergen, Inga V. Leus, Enrico Margiotta, Giuliano Malloci, Andrea Bosin, Attilio V. Vargiu, Olga Lomovskaya, Valentin V. Rybenkov, Paolo Ruggerone, Helen I. Zgurskaya

    Published 2023-08-01
    Get full text
    Article
  4. 4
    Predictive Rules of Efflux Inhibition and Avoidance in Pseudomonas aeruginosa

    Predictive Rules of Efflux Inhibition and Avoidance in Pseudomonas aeruginosa by Jitender Mehla, Giuliano Malloci, Rachael Mansbach, Cesar A. López, Ruslan Tsivkovski, Keith Haynes, Inga V. Leus, Sally B. Grindstaff, Robert H. Cascella, Napoleon D’Cunha, Liam Herndon, Nicolas W. Hengartner, Enrico Margiotta, Alessio Atzori, Attilio V. Vargiu, Pedro D. Manrique, John K. Walker, Olga Lomovskaya, Paolo Ruggerone, S. Gnanakaran, Valentin V. Rybenkov, Helen I. Zgurskaya

    Published 2021-02-01
    Get full text
    Article
  5. 5
    Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial

    Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial... by Richard G. Wunderink, Evangelos J. Giamarellos-Bourboulis, Galia Rahav, Amy J. Mathers, Matteo Bassetti, Jose Vazquez, Oliver A. Cornely, Joseph Solomkin, Tanaya Bhowmick, Jihad Bishara, George L. Daikos, Tim Felton, Maria Jose Lopez Furst, Eun Jeong Kwak, Francesco Menichetti, Ilana Oren, Elizabeth L. Alexander, David Griffith, Olga Lomovskaya, Jeffery Loutit, Shu Zhang, Michael N. Dudley, Keith S. Kaye

    Published 2018-10-01
    Get full text
    Article
  6. 6
    A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens

    A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens by Kade D. Roberts, Yan Zhu, Mohammad A. K. Azad, Mei-Ling Han, Jiping Wang, Lynn Wang, Heidi H. Yu, Andrew S. Horne, Jo-Anne Pinson, David Rudd, Nicolas H. Voelcker, Nitin A. Patil, Jinxin Zhao, Xukai Jiang, Jing Lu, Ke Chen, Olga Lomovskaya, Scott J. Hecker, Philip E. Thompson, Roger L. Nation, Michael N. Dudley, David C. Griffith, Tony Velkov, Jian Li

    Published 2022-03-01
    Get full text
    Article

Search Tools: